Llwytho...
Systematic conversion to generic tacrolimus in stable kidney transplant recipients
BACKGROUND: Tacrolimus (Prograf(®)) is a key drug in the immunosuppressive treatment of renal transplant patients. Since the expiration of the patent for Prograf(®), generic preparations have been approved in Europe as bioequivalence has been shown in healthy volunteers. However, few studies have in...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3970341/ https://ncbi.nlm.nih.gov/pubmed/24944783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfu015 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|